Business Information
The group's principal activity is to design, develop, manufacture, and market invitro diagnostic imaging systems for urinalysis testing. This testing is based on patented and proprietary automated intelligent microscopy technology for automating microscopic procedures performed in clinical laboratories, as well as special purpose centrifuges and other small instruments. The group through its subsidiary manufactures and markets a variety of benchtop centrifuges, small instruments and supplies for the laboratory market. These products are used primarily for manual specimen preparation and dedicated applications in cytology, hematology and urinalysis. The products are sold directly to hospitals, clinical and research laboratories and veterinary and physician offices and also through distributors.
|
|
Name |
Title
|
Email
|
| Richard Williams | Chmn. | N/A | | Peter Donato | CFO, Corporate VP | N/A | | Veronica Tarrant | Interim CFO, VP - Finance, Corporate Controller | N/A | | John Yi | Corporate VP - Operations | N/A | | Cesar Garcia | Dir., CEO, Pres. | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 70,494 | (175) | | 2005 | 62,780 | 6,131 | | 2004 | 43,650 | 2,280
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
